192 related articles for article (PubMed ID: 31726977)
1. The assessment of efficient representation of drug features using deep learning for drug repositioning.
Moridi M; Ghadirinia M; Sharifi-Zarchi A; Zare-Mirakabad F
BMC Bioinformatics; 2019 Nov; 20(1):577. PubMed ID: 31726977
[TBL] [Abstract][Full Text] [Related]
2. deepDR: a network-based deep learning approach to in silico drug repositioning.
Zeng X; Zhu S; Liu X; Zhou Y; Nussinov R; Cheng F
Bioinformatics; 2019 Dec; 35(24):5191-5198. PubMed ID: 31116390
[TBL] [Abstract][Full Text] [Related]
3. SNF-NN: computational method to predict drug-disease interactions using similarity network fusion and neural networks.
Jarada TN; Rokne JG; Alhajj R
BMC Bioinformatics; 2021 Jan; 22(1):28. PubMed ID: 33482713
[TBL] [Abstract][Full Text] [Related]
4. Drug Repositioning by Integrating Known Disease-Gene and Drug-Target Associations in a Semi-supervised Learning Model.
Le DH; Nguyen-Ngoc D
Acta Biotheor; 2018 Dec; 66(4):315-331. PubMed ID: 29700660
[TBL] [Abstract][Full Text] [Related]
5. Predicting drug-target interaction network using deep learning model.
You J; McLeod RD; Hu P
Comput Biol Chem; 2019 Jun; 80():90-101. PubMed ID: 30939415
[TBL] [Abstract][Full Text] [Related]
6. In silico drug repositioning using deep learning and comprehensive similarity measures.
Yi HC; You ZH; Wang L; Su XR; Zhou X; Jiang TH
BMC Bioinformatics; 2021 Jun; 22(Suppl 3):293. PubMed ID: 34074242
[TBL] [Abstract][Full Text] [Related]
7. Drug repositioning of herbal compounds via a machine-learning approach.
Kim E; Choi AS; Nam H
BMC Bioinformatics; 2019 May; 20(Suppl 10):247. PubMed ID: 31138103
[TBL] [Abstract][Full Text] [Related]
8. Predicting associations among drugs, targets and diseases by tensor decomposition for drug repositioning.
Wang R; Li S; Cheng L; Wong MH; Leung KS
BMC Bioinformatics; 2019 Dec; 20(Suppl 26):628. PubMed ID: 31839008
[TBL] [Abstract][Full Text] [Related]
9. Drug Repositioning via Graph Neural Networks: Identifying Novel JAK2 Inhibitors from FDA-Approved Drugs through Molecular Docking and Biological Validation.
Yasir M; Park J; Han ET; Park WS; Han JH; Chun W
Molecules; 2024 Mar; 29(6):. PubMed ID: 38542998
[TBL] [Abstract][Full Text] [Related]
10. DLDTI: a learning-based framework for drug-target interaction identification using neural networks and network representation.
Zhao Y; Zheng K; Guan B; Guo M; Song L; Gao J; Qu H; Wang Y; Shi D; Zhang Y
J Transl Med; 2020 Nov; 18(1):434. PubMed ID: 33187537
[TBL] [Abstract][Full Text] [Related]
11. Using Drug Expression Profiles and Machine Learning Approach for Drug Repurposing.
Zhao K; So HC
Methods Mol Biol; 2019; 1903():219-237. PubMed ID: 30547445
[TBL] [Abstract][Full Text] [Related]
12. Computational drug repositioning using meta-path-based semantic network analysis.
Tian Z; Teng Z; Cheng S; Guo M
BMC Syst Biol; 2018 Dec; 12(Suppl 9):134. PubMed ID: 30598084
[TBL] [Abstract][Full Text] [Related]
13. Integration of various protein similarities using random forest technique to infer augmented drug-protein matrix for enhancing drug-disease association prediction.
Kitsiranuwat S; Suratanee A; Plaimas K
Sci Prog; 2022; 105(3):368504221109215. PubMed ID: 35801312
[TBL] [Abstract][Full Text] [Related]
14. Prediction of Potential Drug-Disease Associations through Deep Integration of Diversity and Projections of Various Drug Features.
Xuan P; Song Y; Zhang T; Jia L
Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31443472
[TBL] [Abstract][Full Text] [Related]
15. In silico drug repositioning: what we need to know.
Liu Z; Fang H; Reagan K; Xu X; Mendrick DL; Slikker W; Tong W
Drug Discov Today; 2013 Feb; 18(3-4):110-5. PubMed ID: 22935104
[TBL] [Abstract][Full Text] [Related]
16. In silico drug repositioning based on the integration of chemical, genomic and pharmacological spaces.
Chen H; Zhang Z; Zhang J
BMC Bioinformatics; 2021 Feb; 22(1):52. PubMed ID: 33557749
[TBL] [Abstract][Full Text] [Related]
17. Drug repurposing: Iron in the fire for older drugs.
Sonaye HV; Sheikh RY; Doifode CA
Biomed Pharmacother; 2021 Sep; 141():111638. PubMed ID: 34153846
[TBL] [Abstract][Full Text] [Related]
18. Drug Repositioning Based on Deep Sparse Autoencoder and Drug-Disease Similarity.
Lei S; Lei X; Chen M; Pan Y
Interdiscip Sci; 2024 Mar; 16(1):160-175. PubMed ID: 38103130
[TBL] [Abstract][Full Text] [Related]
19. Deep fusion learning facilitates anatomical therapeutic chemical recognition in drug repurposing and discovery.
Wang X; Liu M; Zhang Y; He S; Qin C; Li Y; Lu T
Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34368838
[TBL] [Abstract][Full Text] [Related]
20. Additional Neural Matrix Factorization model for computational drug repositioning.
Yang X; Zamit L; Liu Y; He J
BMC Bioinformatics; 2019 Aug; 20(1):423. PubMed ID: 31412762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
